UBS Group »

Nls Pharmaceutics shares owned by UBS Group

Quarter-by-quarter ownership of Nls Pharmaceutics (NLSP) shares owned by UBS Group from 13F filings

Historical chart of UBS Group investment in Nls Pharmaceutics

Tip: Access up to 7 years of quarterly data

All positions including Nls Pharmaceutics held by UBS Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Nls Pharmaceutics by UBS Group

Quarter filed Position value Share count Share price at filing
2025-09-30 $69 38 1.84
2025-06-30 $43k 15k 2.90
2025-03-31 $40k 26k 1.54
2024-12-31 $18k 8.3k 2.11
2024-09-30 $24k 4.7k 5.07

More positions owned by UBS Group

Spdr S&p 500 Etf Tr Tr Unit (SPY)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Amazon (AMZN)
Broadcom (AVGO)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
JPMorgan Chase & Co. (JPM)
Alphabet Cap Stk Cl C (GOOG)
Ubs Group SHS (UBS)
Tesla Motors (TSLA)
Ishares Tr Russell 2000 Etf (IWM)
Visa Com Cl A (V)

View all positions for UBS Group

Top funds holding Nls Pharmaceutics

BVF
Morgan Stanley
UBS Group

View all funds holding Nls Pharmaceutics